EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 85 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,259,109 | -2.8% | 533,055 | +5.8% | 0.00% | – |
| Q2 2023 | $4,382,016 | +231.1% | 503,680 | +11.9% | 0.00% | – |
| Q1 2023 | $1,323,662 | -58.0% | 450,225 | -49.9% | 0.00% | – |
| Q4 2022 | $3,148,292 | -8.2% | 899,512 | +107.4% | 0.00% | – |
| Q3 2022 | $3,431,000 | +7.9% | 433,732 | +7.3% | 0.00% | – |
| Q2 2022 | $3,180,000 | -30.3% | 404,060 | +7.6% | 0.00% | – |
| Q1 2022 | $4,562,000 | +4.3% | 375,470 | +5.1% | 0.00% | – |
| Q4 2021 | $4,374,000 | +38.7% | 357,361 | +18.1% | 0.00% | – |
| Q3 2021 | $3,153,000 | +54.7% | 302,629 | +33.5% | 0.00% | – |
| Q2 2021 | $2,038,000 | – | 226,649 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,490,921 | $27,892,459 | 24.59% |
| ACUTA CAPITAL PARTNERS, LLC | 300,128 | $2,398,023 | 1.61% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,492,147 | $27,902,255 | 1.51% |
| Cormorant Asset Management, LP | 3,200,000 | $25,568,000 | 1.49% |
| Samsara BioCapital, LLC | 432,000 | $3,451,680 | 1.06% |
| Ghost Tree Capital, LLC | 325,000 | $2,596,750 | 0.85% |
| RA Capital Management | 3,370,506 | $26,930,343 | 0.53% |
| Ikarian Capital, LLC | 4,487 | $3,585,113 | 0.43% |
| Affinity Asset Advisors, LLC | 155,000 | $1,238,450 | 0.35% |
| SECTORAL ASSET MANAGEMENT INC | 176,080 | $1,406,879 | 0.27% |